Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Disease-Modifying Antirheumatic Drugs in Children With Juvenile Idiopathic Arthritis

Slide: 42 of 46

Evaluating JIA Assessment Instruments: Conclusions (2 of 2)

Current evidence is inadequate to fully understand the validity, reliability, and responsiveness of the clinical outcomes measures that are used in composite assessments of JIA (such as the ACR Pediatric).

An outcome instrument that accurately describes all aspects of JIA—including disease activity, functional status, and quality of life—is needed to improve both comparative effectiveness research and understanding of the overall impact of JIA.